Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure: Long-Term Follow-Up Extension Study

NCT06577857 is registered in ClinicalTrials.gov with Sanoculis Ltd as lead sponsor.

NCT NCT06577857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06577857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure: Long-Term Follow-Up Extension Study
Lead sponsor
Sanoculis Ltd
Phase
Observational
Overall status
Recruiting
Start date
November 4, 2022
Completion date
June 30, 2025
Enrollment
53 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

open angle glaucoma